International Medical Director – Urgo Medical (APAC, Middle East and South Africa), United Arab Emirates
Special Issue Article
The Explorer study �?? How has it affected the international view of diabetic foot ulcer management?
Author(s): Emilio Galea
The Explorer Study, published on the Lancet in March 2018, was a high level double blind RCT that showed that the use of sucrose octusalfate can reduce healing time of neuro-ischemic DFUs by 60 days. Previous studies also portrayed reduction in healing time for other chronic wounds such as VLUs and PIs with TLC-NOSF.
During this presentation we will give a very brief overview of the study but moreover show how the international community has reacted to these results. Recently the IWGDG has included TLC-NOSF in their guidelines and NICE (UK) has recommended the use of this modality for all chronic wound patients in the UK. This has also been taken on board by D-Foot International in their DFU referral pathway and over 100 protocols in Europe include the same in their recommendations.
The presentation will also include advice on how to implement a 3 tier progra.. View More»